Drug Discovery - Medicine.net

Drug Discovery

Sub Categories on Drug Discovery

{{items.name}}

Latest Articles

Beneficial genetic changes observed in regular blood donors

Beneficial genetic changes observed in regular blood donors

Updated on: April 22,2025

Beneficial genetic changes observed in regular blood donors

Beneficial genetic changes observed in regular blood donors

Updated on:April 22,2025

Common antibiotic found 99.9% effective against typhoid

Common antibiotic found 99.9% effective against typhoid

Updated on: July 09,2025

Common antibiotic found 99.9% effective against typhoid

Common antibiotic found 99.9% effective against typhoid

Updated on:July 09,2025

CRISPR cuts gene from head and neck cancers through direct injection—50% of tumors eliminated in

CRISPR cuts gene from head and neck cancers through direct injection—50% of tumors eliminated in

Updated on: April 22,2025

CRISPR cuts gene from head and neck cancers through direct injection—50% of tumors eliminated in

CRISPR cuts gene from head and neck cancers through direct injection—50% of tumors eliminated in

Updated on:April 22,2025

DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC

Updated on: September 29,2025

DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC

Updated on:September 29,2025

Weekly Update of Drug News-18/9/2025

Weekly Update of Drug News-18/9/2025

Updated on: September 18,2025

Weekly Update of Drug News-18/9/2025

Weekly Update of Drug News-18/9/2025

Updated on:September 18,2025

Weekly Update of Drug News-25/6/2025

Weekly Update of Drug News-25/6/2025

Updated on: June 28,2025

Weekly Update of Drug News-25/6/2025

Weekly Update of Drug News-25/6/2025

Updated on:June 28,2025

New options are advancing rare brain cancer treatment

New options are advancing rare brain cancer treatment

Updated on: September 05,2025

New options are advancing rare brain cancer treatment

New options are advancing rare brain cancer treatment

Updated on:September 05,2025

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Updated on: October 03,2025

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Updated on:October 03,2025

Recommendations developed for young adult cancer survivor follow-up care

Recommendations developed for young adult cancer survivor follow-up care

Updated on: October 06,2025

Recommendations developed for young adult cancer survivor follow-up care

Recommendations developed for young adult cancer survivor follow-up care

Updated on:October 06,2025

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Updated on: October 06,2025

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Updated on:October 06,2025

Categories

Allergy&Clinical immunology

Anesthesiology & Pain

Cardiovascular Diseases

Diabetes & Endocrinology

Emergency Medicine & Critical Care

Family Medicine

Gastroenterology

General Surgery

Hematology&Oncology

Infectious Diseases

Nephrology & Urology

Orthopedics & Sports medicine

Plastic Surgery

Psychiatry & Mental Health

Public Health & Prevention